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Sir,
Orthopedic surgeons commonly encounter cases of shoul-
der pain in their clinical practice, differential diagnosis of
which includes, but is not limited to, septic arthritis. Usu-
ally perceived as ‘benign’, shoulder pain may be a har-
binger of a serious underlying disorder including
hematological malignancies. Jain et al. recently reported a
case of chronic myeloid leukemia (CML) presenting as
shoulder pain mimicking septic arthritis, and later diag-
nosed as myeloid sarcoma (MS) [1]. MS represents an
extramedullary accumulation of immature cells of granu-
locytic series and occurs most commonly in the setting of
acute myeloid leukemia (AML), where its incidence is
2–8 %, occurring after (50 %), prior to diagnosis (25 %) or
concurrently (15–35 %) with AML and may rarely be a
first site of AML relapse. Diagnosis requires fine needle
aspiration (FNA) and immunohistochemistry (MS being
positive for myeloperoxidase) [1]. Although bone and
periosteum are amongst the commonest sites of MS, joint
involvement is extremely rare and results from tumor
invasion of the cortex and medulla resulting into a soft
tissue mass [3]. Considering the shoulder as an important
though rare site of MS, we reviewed all cases of MS in the
English literature involving the shoulder. A brief review of
all cases of shoulder MS, including their clinical/
radiological findings, treatment and outcome is presented
in Table 1 [1–6]. Amongst six cases of shoulder MS, CML
was the commonest underlying etiology, and in one of
them MS was an initial presentation of CML. Males in
their fourth decade were most commonly affected. Pain and
mass in the shoulder were the commonest presenting
complaints. Examination could identify splenomegaly (two
cases) and axillary lymphadenopathy (one case), and MRI
could identify a soft tissue mass (five cases) with or
without an associated lytic lesion. From an orthopedic view
point, septic arthritis was the commonest primary diagno-
sis. All the cases of CML received tyrosine kinase inhibi-
tors, and three of them also received an additional systemic
chemo-radiotherapy. Prognosis of shoulder MS is guarded
and long term survival is unreported. Though MS is
uncommon in CML, myelodysplastic syndrome and other
myeloproliferative neoplasms, our literature review iden-
tified CML as the leading diagnosis in cases of MS of the
shoulder. Considering its rarity, no definite treatment
guidelines are available. Although systemic chemotherapy
followed by allogeneic stem cell transplantation clearly
offers a survival advantage in cases of MS, lack of matched
sibling/unrelated donors and financial costs are real con-
cerns in developing countries like India, where combined
chemo-radiotherapy holds promise as the best form of
‘palliation’ due to lack of its survival benefits and the
poorer prognosis of such cases [1]. We conclude that,
although septic arthritis is the commonest entity producing
shoulder pain and swelling, presence of an associated
lymphadenopathy, splenomegaly, soft tissue component
with/without lytic lesion on MRI, peripheral leucocytosis
with immature granulocytes/blasts, and absence of
response to antibiotics should prompt an orthopedic sur-
geon to seek a hematology consultation maintaining a high
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henceforth realize the urgent need for FNA, and the
importance of performing immunohistochemistry (IHC) in
cases of septic arthritis with the above features being
referred from the orthopedic side for timely and accurate
diagnosis and treatment.
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